Azerbaijan National Academy of Science

Out of 93 samples only 14 will pass further tests. They were selected as part of a project by the US presidential administration to accelerate the creation of the vaccine. According to him, she will be ready in early 2021

In the United States, researchers selected 14 coronavirus vaccine samples for testing. This was reported by NBC, citing a source in the presidential administration.

According to the channel, 14 of the most promising options were chosen from 93 samples that were provided by more than 80 pharmaceutical companies. They will be participating in further trials as part of the Trump administration's project to accelerate the creation of the Warp Speed ​​vaccine. NBC notes that clinical trials will begin this month. According to authorities, the channel reports, as a result, mankind can receive three or four vaccines for widespread use.

rbc.ru